$1,000 pill now hepatitis C treatment of choice

Home › $1,000 pill now hepatitis C treatment of choice

In less than six months, prescriptions for Sovaldi have eclipsed all other hepatitis C pills combined, according to new data from IMS Health.

20.09	Labelexpo Americas highlights, Maxcess announces acquisition and more
20.09	September Cattle on Feed as expected
20.09	USDA announces major investment in meat and poultry processing
20.09	Atlantic Tropical Weather Outlook
20.09	Eastern North Pacific Tropical Weather Outlook
20.09	This weeks lesson: Weaning matters in the cattle market
20.09	Construction giant collapses putting 2,400 jobs at risk
20.09	KANSAI HELIOS Further Expands as System Supplier in Italy
More »

je.st